Robert P Schwartz

Dados Biográficos

ID5544022
NOMERobert P Schwartz
PRENOMESRobert P
SOBRENOMESchwartz
ASSINATURASCHWARTZ R P
AFILIAÇÕESFriends Research Institute
ORCID0000-0002-4707-5726
VERIFICADOSim
TOTAL DE OBRAS27
TOTAL DE CITAÇÕES10
TOTAL COMO AUTOR27
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO1970
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H2

  • Barriers to Buprenorphine Treatment Among People Experiencing Homelessness

    Open AccessCarmen L Masson, Valerie A Gruber et al.ARTICLEJournal of Urban Health2025Referências: 1

    People experiencing homelessness (PEH) face a high risk of opioid-related deaths, yet there is limited qualitative data on the barriers encountered when accessing buprenorphine treatment for opioid use disorder (OUD). To address this gap, we interviewed 28 clinicians, outreach workers, and administrators from organizations serving PEH with OUD. Our goal was to understand the barriers and facilitators at the patient, clinic, and institutional leve…

  • The Relationship between Vaping Cannabis and Frequency of Cannabis Use and Cannabis-Related Problems among Urban High School Students

    Miaisha M Mitchell, Mary M Mitchell et al.ARTICLESubstance Use & Misuse2024

    Background: Vaping, including vaping cannabis, is increasing among adolescents. In this longitudinal study, we examined the relationship between vaping cannabis and frequency of cannabis use and related problems over 6 months among adolescents. Material and Methods: Data were from 233 participants (46.8% male, 93.1% African American, mean age = 16.4 years) reporting cannabis use. The Alcohol, Smoking and Substance Involvement Screening Test (ASSI…

  • The impact of Covid-19 on the treatment of opioid use disorder in carceral facilities

    Open AccessElizabeth C Saunders, Milan F Satcher et al.ARTICLEHealth & Justice2022

    While the COVID-19 pandemic disrupted healthcare delivery everywhere, persons with carceral system involvement and opioid use disorder (OUD) were disproportionately impacted and vulnerable to severe COVID-associated illness. Carceral settings and community treatment programs (CTPs) rapidly developed protocols to sustain healthcare delivery while reducing risk of COVID-19 transmission. This survey study assessed changes to OUD treatment, telemedic…

  • Cost and Cost Savings of Navigation Services to Avoid Rehospitalization for a Comorbid Substance Use Disorder Population

    Stephen Orme, Gary A Zarkin et al.ARTICLEMedical Care2022Referências: 16

    BACKGROUND: A randomized clinical trial found that patient navigation for hospital patients with comorbid substance use disorders (SUDs) reduced emergency department (ED) and inpatient hospital utilization compared with treatment-as-usual. OBJECTIVE: To compare the cost and calculate any cost savings from the Navigation Services to Avoid Rehospitalization (NavSTAR) intervention over treatment-as-usual. RESEARCH DESIGN: This study calculates activ…

  • Organizational Acceptability of Implementing SBIRT for Adolescents in Primary Care

    Laura B Monico, Shannon Gwin Mitchell et al.ARTICLESubstance Use & Misuse2021

    Introduction Adolescent illicit drug, tobacco, and alcohol use can result in sudden and long-term negative health consequences. Primary care environments present the optimal opportunity for screening and brief interventions that target prevention and curtailing use. Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a service delivery method that could potentially be well-integrated into primary care settings and used to serve a …

  • HIV-Risk Behavior Among Adults with Opioid Use Disorder During 12 Months Following Pre-trial Detention

    Open AccessMiaisha M Mitchell, Sharon M Kelly et al.ARTICLEAIDS and Behavior2020

  • Physician Mistrust, Medical System Mistrust, and Perceived Discrimination

    Open AccessAhnalee Brincks, Karen Shiu‐yee et al.ARTICLEAIDS and Behavior2019

  • A Latent Class Analysis of HIV Risk Factors Among Men and Women with Opioid Use Disorder in Pre-trial Detention

    Open AccessMiaisha M Mitchell, Jan Gryczynski et al.ARTICLEAIDS and Behavior2019

  • Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users

    Open AccessKaren Shiu‐yee, Ahnalee Brincks et al.ARTICLEAIDS and Behavior2018

  • Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly “Drug-Free” Outpatient Programs

    Laura B Monico, Laura Monico et al.ARTICLEJournal of Psychoactive Drugs2016

    Drug-free" outpatient programs deliver treatment to the largest number of patients of all treatment modalities in the U.S., providing a significant opportunity to expand access to medication treatments for substance use disorders. This analysis examined staff perceptions of organizational dynamics associated with the delivery of buprenorphine maintenance within three formerly "drug-free" outpatient treatment programs. Semi-structured interviews (…

  • Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

    Open AccessDiana Hernández, Daniel J Feaster et al.ARTICLEAIDS and Behavior2015

  • Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use

    Shannon Gwin Mitchell, Laura B Monico et al.ARTICLEJournal of Psychoactive Drugs2015

    The use of computers for identifying and intervening with stigmatized behaviors, such as drug use, offers promise for underserved, rural areas; however, the acceptability and appropriateness of using computerized brief intervention (CBIs) must be taken into consideration. In the present study, 12 staff members representing a range of clinic roles in two rural, federally qualified health centers completed semi-structured interviews in a qualitativ…

  • Changes in Quality of Life following Buprenorphine Treatment

    Shannon Gwin Mitchell, Jan Gryczynski et al.ARTICLEJournal of Psychoactive Drugs2015

    Studies of substance abuse treatment outcomes that give priority to cessation of all drug use may obscure other tangible benefits of treatment that are important to patients. The aim of this study was to examine the association between changes in quality of life (QoL) and: (1) retention in treatment; and (2) opioid use as measured by self-report and urine testing. Participants were 300 African American men and women starting outpatient buprenorph…

  • Patient Perspectives on Buprenorphine/Naloxone

    Cheryl Teruya, Robert P Schwartz et al.ARTICLEJournal of Psychoactive Drugs2014

    This study examines the barriers and facilitators of retention among patients receiving buprenorphine/naloxone at eight community-based opioid treatment programs across the United States. Participants (n = 105) were recruited up to three and a half years after having participated in a randomized clinical trial comparing the effect of buprenorphine/naloxone and methadone on liver function. Semi-structured interviews were conducted with 67 patients…

  • Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009

    Robert P Schwartz, Jan Gryczynski et al.ARTICLEAmerican Journal of Public Health2013Citada por: 6Referências: 41

    Objectives. We examined the association between the expansion of methadone and buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore, Maryland from 1995 to 2009. Methods. We conducted a longitudinal time series analysis of archival data using linear regression with the Newey–West method to correct SEs for heteroscedasticity and autocorrelation, adjusting for average heroin purity. Results. Overdose deaths attributed to…

  • Schwartz et al. Respond

    Robert P Schwartz, Jan Gryczynski et al.ARTICLEAmerican Journal of Public Health2013Referências: 3

    As reported in our recent article, which found an association between expansion of methadone and buprenorphine treatment and the reduction in heroin overdose deaths in Baltimore, Maryland, between 1995 and 2009, the distribution of the opioid antagonist naloxone is one of a number of public health strategies being employed in the United States and United Kingdom (among other countries) to reduce opioid overdose deaths.1–4 From 2004 through 2009, …

  • Redefining Retention

    Shannon Gwin Mitchell, Rika Morioka et al.ARTICLEJournal of Psychoactive Drugs2011

    This study examines the process of discharge and treatment reentry for six participants who entered treatment voluntarily but were administratively discharged from methadone treatment programs. The participants completed semistructured interviews at treatment entry and at four, eight and 12 months post-treatment entry. Grounded theory methodology was used to examine the phenomenon of treatment reentry from the perspective of the patients, who oft…

  • Why don’t out-of-treatment individuals enter methadone treatment programmes

    Open AccessJames A Peterson, Robert P Schwartz et al.ARTICLEInternational Journal of Drug…2010

  • Impact of Interim Methadone Maintenance on HIV Risk Behaviors

    Open AccessMonique E Wilson, Robert P Schwartz et al.ARTICLEJournal of Urban Health2010

  • Premature Discharge from Methadone Treatment

    Heather Schacht Reisinger, Robert P Schwartz et al.ARTICLEJournal of Psychoactive Drugs2009

    Longer retention in drug abuse treatment is associated with better patient outcomes, and research indicates the first 12 months of methadone treatment are critical to patient success. Nevertheless, large-scale multisite longitudinal studies over the past three decades indicate that the majority of patients drop out during the first year of methadone treatment. Through an examination of 42 qualitative interviews with patients prematurely discharge…

  • Incarceration and Opioid Withdrawal

    Shannon Gwin Mitchell, Sharon M Kelly et al.ARTICLEJournal of Psychoactive Drugs2009

    Both heroin-addicted individuals and methadone maintenance patients are likely to face untreated opioid withdrawal while incarcerated. Limited research exists concerning the withdrawal experiences of addicted inmates and their impact on individuals' attitudes and plans concerning drug abuse treatment. In the present study, 53 opioid dependent adults (32 in methadone treatment and 21 out of treatment) were interviewed in an ethnographic investigat…

  • Targeted Sampling in Drug Abuse Research

    Open AccessJames A Peterson, Heather Schacht Reisinger et al.ARTICLECAM2008

    Locating and recruiting out-of-treatment drug-dependent individuals for inclusion in research studies are important and challenging tasks. Targeted sampling, a technique to reach such populations, has been described in the substance abuse literature. However, this literature has generally lacked a recent detailed account of the procedures for planning and implementing targeted sampling. This article provides a review of the literature of targeted…

  • Prevalence and correlates of HCV infection among methadone maintenance attendees

    Open AccessAnita M Loughlin, Rachel Schwartz et al.ARTICLEInternational Journal of Drug…2004

  • Reflections on Projection

    Rachel Schwartz, Robert Schwartz et al.ARTICLEProtoSociology1998

  • The Power of Pictures

    Robert Schwartz, Robert P SchwartzARTICLEThe Journal of Philosophy1985Citada por: 3

    Malgre une apparence de paradoxe, l'idee que la maniere dont un peintre represente la realite peut influencer notre maniere de voir cette realite est, selon l'A., en grande partie correcte. Il developpe donc la composante active de la representation picturale, examine quelques contre-exemples (lies a la notion de ressemblance : peut-on encore ressembler au portrait d'une autre personne?), et etend son analyse de l'activite artistique a l'activite…